- 询价
- 辰辉创聚生物®️
- 中国
- NBAB-188678
- 2026年05月21日
- FC
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Recombinant Human CD49d protein
- 形态：
liquid
- 保存条件：
见COA
- 克隆性：
单克隆
- 保质期：
见COA
- 库存：
大量
- 供应商：
北京辰辉创聚生物技术有限公司
- 应用范围：
FC
- 抗体英文名：
Anti-CD49d Monoclonal Antibody
- 抗体名：
抗CD49d单抗
- 规格：
100ul; 500ul; 1ml
| 产品信息
品名：NebuSelect™ Anti-CD49d Monoclonal Antibody
货号：NBAB-188678
品牌：辰辉创聚生物®️
规格：100ul; 500ul; 1ml
| 产品描述
NebuSelect™ Anti-CD49d Monoclonal Antibody (Cat# NBAB-188678) was produced in Mouse immunized with Recombinant Human CD49d protein, and it reacts with Human. This antibody is validated for FC.
| 产品属性
Product Category：Mouse MAb
Reactivity：Human
Specificity：Human CD49d
Immunogen：Recombinant Human CD49d protein
Isotype：Monoclonal Mouse IgG
Purification：Protein A & Protein G Affinity Purification
Buffer：0.2 μm filtered solution in PBS, pH7.4, containing 0.09% Sodium azide, 50% glycerol.
Conjugate：Unconjugated
Applications：FC
Dilution：FC 1:20～1:200
Storage：This liquid antibody can be stored at 2℃-8℃ for at least two weeks. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20℃. When reconstituted in sterile pH 7.4 0.01M PBS or antibody diluent, the antibody is stable for at least two weeks at 2-4℃.
For Research Use Only!
To get more information, please contact us freely.
郑重声明：仅用于科学研究，不可用于诊断或治疗。
更多产品细节，请联系我司相关客服人员。
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验ITGA4（CD49D）信号通路、病理作用与靶向治疗药物研究梳理
的靶向治疗 ITGA4及其相关整合素的靶向治疗已涌现出多款单抗药物。Natalizumab作为靶向CD49D的药物，早在2004年便获批用于多发性硬化及克罗恩病。针对α4β7整合素的药物研发也取得了显著进展：武田制药的Vedolizumab已获全球多国批准，通过阻断α4β7与MAdCAM-1相互作用抑制免疫细胞迁移，近期KEPLER试验更证实其对2岁及以上UC患者的疗效；Amgen开发的Abrilumab在2b期研究中显著提升了中重度UC患者的临床缓解率；而Etrolizumab目前正处于全球Ⅲ
Notes on Making Rat x Y3 Monoclonal Antibody Producing Hybridomas
are very stable - even in long term large scale cultures (bioreactors). b) High levels of monoclonal antibody secretion in culture - often 100 micrograms per ml of ordinary tissue culture, without recloning, and up to 5 milligrams per ml in hollow fibre
The production of monoclonal antibody by hybridoma
antibody of predefined specificity.1975. Nature 256: 495-497. 2) Lane, R.D. A short duration polyethylene glycol fusion technique for increasing production of monoclonal antibody-secreting hybridomas. 1985. J. Immunol. Meth
技术资料暂无技术资料 索取技术资料
